RESEARCH ALERT-Clovis Oncology: Leerink Swann raises target price
November 21, 2013 at 06:04 AM EST
Nov 21 (Reuters) - Clovis Oncology Inc : * Leerink Swann raises target price to $94 from $88; rating outperform For a summary of rating and price target changes on U.S. companies: Reuters Eikon users, click on Reuters 3000Xtra users, double-click Thomson ONE users, type in RT/RCH/US For a summary of rating and price target changes on Canadian companies: Reuters Eikon users, click on Reuters 3000Xtra users, double-click Thomson ONE users, type in RT/RCH/CA
